Inventaire - your friends and communities are your best library

A surface plasmon resonance assay for measurement of neuraminidase inhibition, sensitivity of wild-type influenza neuraminidase and its H274Y mutant to the antiviral drugs zanamivir and oseltamivir

author

Balaji Somasundaram

Andrew J.A. Watson

Antony J. Fairbanks

Richard Hall

published in: Journal of Molecular Recognition

date of publication: 2015-03-02

main subject: Surface plasmon resonance, zanamivir, oseltamivir

Cites articles 21

Date

Title

Authors

2015-01-20

Development of a surface plasmon resonance assay to measure the binding affinity of wild-type influenza neuraminidase and its H274Y mutant to the antiviral drug zanamivir

Balaji Somasundaram, Andrew J.A. Watson, Antony J. Fairbanks
2014-02-18

A phospha-oseltamivir-biotin conjugate as a strong and selective adhesive for the influenza virus

Peter J Coombs
2013-01-01

Assays for monitoring susceptibility of influenza viruses to neuraminidase inhibitors

Larisa Gubareva, Margaret Okomo Adhiambo
2012-11-13

Chemical probes for drug-resistance assessment by binding competition (RABC): oseltamivir susceptibility evaluation

Jim-Min Fang, Chi-Huey Wong
2010-09-01

Structural and functional basis of resistance to neuraminidase inhibitors of influenza B viruses

Aaron J. Oakley, Susan A. Barrett, Thomas S. Peat, Janet Newman, Jennifer McKimm-Breschkin, Victor A Streltsov, Takehiko Saito
2009-10-01

Structural basis for oseltamivir resistance of influenza viruses

John Skehel
2009-01-01

New antivirals and drug resistance
2008-05-14

Crystal structures of oseltamivir-resistant influenza virus neuraminidase mutants

Junfeng Liu, Steven Gamblin, John Skehel
2007-12-11

Mutations of neuraminidase implicated in neuraminidase inhibitors resistance
2007-12

The war against influenza: discovery and development of sialidase inhibitors
2006-08-16

The structure of H5N1 avian influenza neuraminidase suggests new opportunities for drug design.

Steven Gamblin, John Skehel
2005-09-01

Avian influenza (H5N1) viruses isolated from humans in Asia in 2004 exhibit increased virulence in mammals

Kristy J Szretter, Sherif Zaki, Jacqueline M. Katz, Ruben O Donis, Terrence M Tumpey, Taronna R Maines, Nancy Cox, Wilina Lim, Pranee Thawatsupha, Malinee Chittaganpitch, Sunthareeya Waicharoen
2004-12-09

Detection of influenza virus: traditional approaches and development of biosensors
2003-02-01

Evaluation of neuraminidase enzyme assays using different substrates to measure susceptibility of influenza virus clinical isolates to neuraminidase inhibitors: report of the neuraminidase inhibitor susceptibility network

Jennifer McKimm-Breschkin
2002-05-01

Neuraminidase inhibitors as antivirals
2000-03-01

Influenza virus neuraminidase inhibitors
2000-01-01

Monitoring of viral susceptibility: new challenges with the development of influenza NA inhibitors
1998-11-01

Evidence for zanamivir resistance in an immunocompromised child infected with influenza B virus

Robert G. Webster
1997-01-01

Influenza neuraminidase inhibitors possessing a novel hydrophobic interaction in the enzyme active site: design, synthesis, and structural analysis of carbocyclic sialic acid analogues with potent anti-influenza activity
1979-04-01

Fluorometric assay of neuraminidase with a sodium (4-methylumbelliferyl-alpha-D-N-acetylneuraminate) substrate

Louis Dallaire, Serge B. Melançon
1974-10

Characterization of temperature sensitive influenza virus mutants defective in neuraminidase

Peter Palese

Article - wd:Q38905010

Welcome to Inventaire

the library of your friends and communities

learn more